Production Small Molecule Synthetic Chemistry 
DrugBaron
FEBRUARY 7, 2022
Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. Yet the situation with small molecules is even worse.
The Strateos Blog: Drug Discovery
SEPTEMBER 24, 2021
In continued efforts to provide scientists with end-to-end technologies to accelerate their workflows, Strateos has expanded its synthetic chemistry solutions with the integration of PerkinElmer Informatics Signals™ electronic lab notebook (ELN). Ben Miles, Ph.D., Ben Miles, Ph.D.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dark Matter Blog
APRIL 8, 2020
All of that, of course, bodes well for a productive long-term relationship. Our Chinese CROs are back online and doing synthetic chemistry at a pre-pandemic pace. Our ambition was to unlock vast swaths of valuable biology inaccessible to medicine today because the proteins involved elude our reach.
The Pharma Data
DECEMBER 4, 2021
AWS is working with Pfizer to develop a prototype solution for detecting abnormal data points in its drug product continuous clinical manufacturing platform for solid oral-dose medicines. Pfizer has an extensive collection of documents that contain valuable data from a variety of drug development processes.
The Strateos Blog: Drug Discovery
FEBRUARY 22, 2022
Strateos’ SVP of Strategy and Operations, Daniel Sipes, gave a presentation outlining how the challenges in conventional design, make, test and analyze (DMTA) cycles in small molecule drug discovery workflows can be overcome with automated end-to-end solutions from synthesis to biological testing.
Expert insights. Personalized for you.
100 
Let's personalize your content